Pfizer has again raised its offer for AstraZeneca, making what it said was a final effort to bring the giant British drug maker to the negotiating table.
The latest offer, made Sunday evening, is worth about $119 billion. It comes after AstraZeneca’s rejection of several private and public offers from Pfizer.